“…However, other groups have challenged this model, suggesting instead that deletion of Mfn2 increases ER-mitochondrial association and, in turn, are questioning whether Mfn2, indeed, localizes to the ER (Filadi et al, 2015;Cosson et al, 2012). Regardless of the role Mfn2 has in ER-mitochondrial contacts, the importance of mitochondrial fusion proteins -particularly in neuronal cells -is highlighted by the fact that hypomorphic mutations in Mfn2 are most often responsible for autosomal dominant Charcot-Marie-Tooth (CMT) disease, axonal, type 2A2 (CMT2A2) (Chapman et al, 2013;Misko et al, 2012;Niemann et al, 2014;Yu-Wai-Man et al, 2011), a common peripheral neuropathy (Züchner et al, 2004), whereas mutations in Opa1 are the most common cause of hereditary blindness, i.e. autosomal dominant optic atrophy (ADOA) (Yu-Wai-Man et al, 2011;Alexander et al, 2000;Zanna et al, 2008).…”